Page last updated: 2024-08-21

dibutylnitrosamine and Disease Exacerbation

dibutylnitrosamine has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brekken, RA; Frierson, HF; Said, N; Sanchez-Carbayo, M; Theodorescu, D	1

Other Studies

1 other study(ies) available for dibutylnitrosamine and Disease Exacerbation

Article	Year
Loss of SPARC in bladder cancer enhances carcinogenesis and progression. The Journal of clinical investigation, 2013, Volume: 123, Issue:2 Topics: Animals; Base Sequence; Cell Cycle Proteins; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Female; Glycoproteins; Humans; Inflammation Mediators; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Nitrosamines; Osteonectin; Precancerous Conditions; RNA, Small Interfering; Tumor Suppressor Proteins; Urinary Bladder Neoplasms; Urothelium	2013

Article

Year

Loss of SPARC in bladder cancer enhances carcinogenesis and progression.

The Journal of clinical investigation, 2013, Volume: 123, Issue:2

Topics: Animals; Base Sequence; Cell Cycle Proteins; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Female; Glycoproteins; Humans; Inflammation Mediators; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Nitrosamines; Osteonectin; Precancerous Conditions; RNA, Small Interfering; Tumor Suppressor Proteins; Urinary Bladder Neoplasms; Urothelium

2013